Earnings Feed
Start Free
Home/Filings/4/0001190251-17-000004
4//SEC Filing

SAUCEDO JOSEPH R 4

Accession 0001190251-17-000004

CIK 0000883984other
View on SEC.govCompany Profile

Filed

Oct 9, 8:00 PM ET

Accepted

Oct 10, 12:44 PM ET

Size

35.1 KB

Accession

0001190251-17-000004

Insider Transaction Report

Form 4
Period: 2017-10-09
ICU MEDICAL INC/DEICUI
SAUCEDO JOSEPH R
Director
Transactions
  • Sale

    Common Stock

    2017-10-09$189.49/sh−4,600$871,640→ 3,291 total
  • Exercise of In-Money

    Common Stock

    2017-10-09$33.52/sh+1,500$50,280→ 6,091 total
  • Exercise of In-Money

    Common Stock

    2017-10-09$43.12/sh+1,500$64,680→ 9,091 total
  • Exercise of In-Money

    Common Stock

    2017-10-09$39.38/sh+1,500$59,070→ 12,091 total
  • Sale

    Common Stock

    2017-10-09$189.01/sh−600$113,408→ 11,491 total
  • Sale

    Common Stock

    2017-10-09$190.67/sh−300$57,200→ 9,091 total
  • Sale

    Common Stock

    2017-10-09$189.00/sh−1,200$226,800→ 7,891 total
  • Sale

    Common Stock

    2017-10-09$190.85/sh−200$38,170→ 3,091 total
  • Exercise of In-Money

    Common Stock

    2017-10-09$32.40/sh+1,500$48,600→ 4,591 total
  • Exercise of In-Money

    Non-Qualified Stock Option (right to buy)

    2017-10-09$33.52/sh−1,500$50,280→ 0 total
    Exercise: $33.52From: 2011-04-21Exp: 2020-04-21→ Common Stock (1,500 underlying)
  • Exercise of In-Money

    Non-Qualified Stock Option (right to buy)

    2017-10-09$39.38/sh−1,500$59,070→ 0 total
    Exercise: $39.38From: 2012-10-19Exp: 2021-10-19→ Common Stock (1,500 underlying)
  • Exercise of In-Money

    Common Stock

    2017-10-09$37.00/sh+1,500$55,500→ 7,591 total
  • Exercise of In-Money

    Common Stock

    2017-10-09$36.60/sh+1,500$54,900→ 10,591 total
  • Sale

    Common Stock

    2017-10-09$189.48/sh−2,100$397,913→ 9,391 total
  • Exercise of In-Money

    Non-Qualified Stock Option (right to buy)

    2017-10-09$32.40/sh−1,500$48,600→ 0 total
    Exercise: $32.40From: 2011-02-03Exp: 2020-02-03→ Common Stock (1,500 underlying)
  • Exercise of In-Money

    Non-Qualified Stock Option (right to buy)

    2017-10-09$36.60/sh−1,500$54,900→ 0 total
    Exercise: $36.60From: 2011-10-20Exp: 2020-10-20→ Common Stock (1,500 underlying)
  • Exercise of In-Money

    Non-Qualified Stock Option (right to buy)

    2017-10-09$37.00/sh−1,500$55,500→ 0 total
    Exercise: $37.00From: 2011-07-21Exp: 2020-07-21→ Common Stock (1,500 underlying)
  • Exercise of In-Money

    Non-Qualified Stock Option (right to buy)

    2017-10-09$43.12/sh−1,500$64,680→ 0 total
    Exercise: $43.12From: 2012-02-02Exp: 2021-02-02→ Common Stock (1,500 underlying)
Footnotes (7)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.25 to $189.20, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.25 to $190.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.40 to $191.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.20 to $189.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.20 to $190.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.70 to $191.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Documents

1 file

Issuer

ICU MEDICAL INC/DE

CIK 0000883984

→
Entity typeother

Related Parties

1
  • filerCIK 0001190251

Filing Metadata

Form type
4
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 12:44 PM ET
Size
35.1 KB
View on SEC.gov